Forecasts data is unavailable for this security.
Consensus recommendation
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Lexeo Therapeutics Inc have a median target of 21.00, with a high estimate of 28.00 and a low estimate of 20.00. The median estimate represents a 162.50% increase from the last price of 8.00.
High | 250.0% | 28.00 |
Med | 162.5% | 21.00 |
Low | 150.0% | 20.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Dec 12, 2024.
Average growth rate | +39.81% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼